Skip to content

Alcohol Research Consortium in HIV-Intervention Research Arm

Alcohol Research Consortium in HIV-Intervention Research Arm

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02938377
Acronym
ARCH-IRA
Enrollment
4985
Registered
2016-10-19
Start date
2017-11-06
Completion date
2023-11-01
Last updated
2025-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcohol Use, HIV Positive

Brief summary

Aim 1: Examine effects of algorithm-guided alcohol treatment on alcohol consumption and alcohol use Disorders (AUD) symptoms. Aim 2: Examine effects of algorithm-guided alcohol treatment on retention in HIV care and HIV-related outcomes. Aim 3: Examine effects of algorithm-guided alcohol treatment on comorbid conditions

Detailed description

Aim 1: Examine effects of algorithm-guided alcohol treatment on alcohol consumption and alcohol use Disorders (AUD) symptoms. Hypothesis 1A: Patients who are treated using algorithm-guided alcohol treatment will decrease drinking quantity and or frequency compared to pre-algorithm levels. Hypothesis 1B. Patients who are treated using algorithm-guided treatment will decrease current AUD symptoms compared to pre-algorithm symptoms levels. Aim 2: Examine effects of algorithm-guided alcohol treatment on retention in HIV care and HIV-related outcomes. Hypothesis 2A. Patients treated using algorithm-guided treatment will increase adherence to clinic visits and HIV medications compared to pre-algorithm levels. Hypothesis 2B. Patients who receive algorithm-guided treatment will have improved HIV biomarkers (e.g., CD4 and VL). Hypothesis 3B. There will be a positive relationship between VL and alcohol consumption measured by self-report and PEth level. Aim 3: Examine effects of algorithm-guided alcohol treatment on comorbid conditions (e.g., depression, anxiety, HCV, other drug use disorders). Hypothesis 3A: Persons living with HIV (PLWH) with co-morbid depression and anxiety receiving algorithm-guided treatment will have better alcohol, mental health and HIV treatment outcomes compared to similar individuals in SC. Hypothesis 3B: PLWH with comorbid HCV receiving algorithm-guided treatment will have improved FIB4 results and reduced likelihood of HCV recurrence compared to persons in SC. Hypothesis 3C: Other drug use will decrease among those receiving algorithm-guided treatment vs SC.

Interventions

BEHAVIORALComputerized Brief Intervention (CBI)

A video which emphasizes personal responsibility for change, uses empathy as a counseling style, and enhances self-efficacy. Depending on alcohol dependence level, four different CBI versions may be shown over two visits.

BEHAVIORALCBT4CBT

9 computerized modules delivered at the participant's pace

DRUGRecommendation and Counseling for Alcohol Pharmacotherapy

The APT algorithm will utilize the four FDA approved APTs for the treatment of alcohol use disorder. The treatment of the patient is part of routine care.

Sponsors

University of Alabama at Birmingham
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Participants were given varying levels of treatment depending on their alcohol use.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* At least 18 years or older; * Receiving HIV care at the UAB, UW or UCSD clinics and not anticipating changing clinics over the next 12 months; * AUDIT-C score \> 3 women or \> 4 men at time of PRO.

Exclusion criteria

* Non-English speaking; * Acutely suicidal, manic, acutely intoxicated, or otherwise not stable enough to provide informed consent.

Design outcomes

Primary

MeasureTime frameDescription
Audit-C Score on a Scale18 month windowDifference in Audit-C score, pre and post intervention. The AUDIT-C is scored on a scale of 0-12 (scores of 0 reflect no alcohol use). In men, a score of 4 or more is considered positive; in women, a score of 3 or more is considered positive. Generally, the higher the AUDIT-C score, the more likely it is that the patient's drinking is affecting his/her health and safety.

Secondary

MeasureTime frameDescription
PEth LevelsBetween baseline and 6 month follow-upPEth is a biomarker for recent alcohol use found in the blood that is specific to ethanol ingestion and can detect low-to heavy drinking levels.

Countries

United States

Participant flow

Participants by arm

ArmCount
Risky Drinking, no dx of AUD, Has Panic or Depression
Computerized Brief Intervention (CBI)- a video about alcohol abuse, plus 4 sessions of counseling called Motivational Enhancement Therapy Computerized Brief Intervention (CBI): A video which emphasizes personal responsibility for change, uses empathy as a counseling style, and enhances self-efficacy. Depending on alcohol dependence level, four different CBI versions may be shown over two visits. CBT4CBT: 9 computerized modules delivered at the participant's pace
115
Dx of AUD With or Without Panic or Depression
Computerized Brief Intervention (CBI)- a video about alcohol abuse, plus 4 sessions of counseling called Motivational Enhancement Therapy plus a recommendation for Alcohol Pharmacotherapy (APT). The drugs recommended in the APT are all standard of care drugs for alcohol treatment and are not under study in this protocol. Computerized Brief Intervention (CBI): A video which emphasizes personal responsibility for change, uses empathy as a counseling style, and enhances self-efficacy. Depending on alcohol dependence level, four different CBI versions may be shown over two visits. CBT4CBT: 9 computerized modules delivered at the participant's pace Recommendation and Counseling for Alcohol Pharmacotherapy: The APT algorithm will utilize the four FDA approved APTs for the treatment of alcohol use disorder. The treatment of the patient is part of routine care.
27
No dx of Alcohol Use Disorder, Panic or Depression
This arm will receive standard of care services at each clinic.
4,843
Total4,985

Baseline characteristics

CharacteristicDx of AUD With or Without Panic or DepressionNo dx of Alcohol Use Disorder, Panic or DepressionRisky Drinking, no dx of AUD, Has Panic or DepressionTotal
Age, Continuous45 years
STANDARD_DEVIATION 11
49 years
STANDARD_DEVIATION 12
48 years
STANDARD_DEVIATION 12
47 years
STANDARD_DEVIATION 12
Race/Ethnicity, Customized
Hispanic
9 Participants649 Participants11 Participants669 Participants
Race/Ethnicity, Customized
Non-Hispanic Black
8 Participants2151 Participants55 Participants2214 Participants
Race/Ethnicity, Customized
Non-Hispanic White
9 Participants1839 Participants45 Participants1893 Participants
Race/Ethnicity, Customized
Other
1 Participants204 Participants4 Participants209 Participants
Sex: Female, Male
Female
3 Participants969 Participants22 Participants994 Participants
Sex: Female, Male
Male
24 Participants3874 Participants93 Participants3991 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
0 / 1150 / 270 / 4,843
other
Total, other adverse events
0 / 1150 / 270 / 4,843
serious
Total, serious adverse events
0 / 1150 / 270 / 4,843

Outcome results

Primary

Audit-C Score on a Scale

Difference in Audit-C score, pre and post intervention. The AUDIT-C is scored on a scale of 0-12 (scores of 0 reflect no alcohol use). In men, a score of 4 or more is considered positive; in women, a score of 3 or more is considered positive. Generally, the higher the AUDIT-C score, the more likely it is that the patient's drinking is affecting his/her health and safety.

Time frame: 18 month window

ArmMeasureValue (MEAN)
Risky Drinking, no dx of AUD, Has Panic or DepressionAudit-C Score on a Scale-1.0 score on a scale
Dx of AUD With or Without Panic or DepressionAudit-C Score on a Scale-2.3 score on a scale
No dx of Alcohol Use Disorder, Panic or DepressionAudit-C Score on a Scale-1.0 score on a scale
Secondary

PEth Levels

PEth is a biomarker for recent alcohol use found in the blood that is specific to ethanol ingestion and can detect low-to heavy drinking levels.

Time frame: Between baseline and 6 month follow-up

Population: As a result of the COVID pandemic, sample collection was disrupted, leading to only 13 samples collected overall. This number of samples was below the 75% threshold needed to justify processing the samples. Samples were never sent for PeTH testing and will not be sent for PeTH testing.

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026